Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. The company is headquartered in Wuxi, Jiangsu and currently employs 12,552 full-time employees. The company went IPO on 2017-06-13. The firm mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The firm mainly conducts its business in the domestic and overseas markets.
Follow-Up Questions
Qui est le CEO de WuXi Biologics (Cayman) Inc ?
Dr. Zhisheng Chen est le Chief Executive Officer de WuXi Biologics (Cayman) Inc, il a rejoint l'entreprise depuis 2014.
Quelle est la performance du prix de l'action WXXWY ?
Le prix actuel de WXXWY est de $10, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de WuXi Biologics (Cayman) Inc ?
WuXi Biologics (Cayman) Inc appartient à l'industrie Life Sciences Tools & Services et le secteur est Health Care
Quelle est la capitalisation boursière de WuXi Biologics (Cayman) Inc ?
La capitalisation boursière actuelle de WuXi Biologics (Cayman) Inc est de $20.3B
Est-ce que WuXi Biologics (Cayman) Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 27 analystes ont établi des notations d'analystes pour WuXi Biologics (Cayman) Inc, y compris 9 achat fort, 17 achat, 6 maintien, 0 vente et 9 vente forte
